Turid Løkeland

Author information from the last article

Turid Løkeland (f. 1966) er overlege.

Forfatter har fylt ut ICMJE-skjemaet og oppgir ingen interessekonflikter.

Haukeland universitetssykehus

Avdeling for kreftbehandling og medisinsk fysikk

Articles by Turid Løkeland

High-dose therapy with autologous stem cell support for lymphoma – from experimental to standard treatment

Knut Bjøro Smeland,
Cecilie E. Kiserud,
Grete F. Lauritzsen,
Alexander Fosså,
Jens Hammerstrøm,
Vidar Jetne,
Arne Kolstad,
Gunnar Kvalheim,
Jon Håvard Loge,
Turid Løkeland,
Jon Magnus Tangen,
Harald Holte,
Stein Kvaløy

03.09.2013: High-dose therapy with autologous stem cell support (HDT) for lymphomas has been given in Norway since 1987. The therapy consists of intensive chemotherapy and/or total body irradiation in such high doses that it entails a life-threatening loss of healthy haematopoietic stem cells in the bone marrow...